Wu G - Search Results

1

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.

Chen J, Liu J, Zhang L, Wu G, Hua W, Wu X, Sun H. Chen J, et al. Among authors: wu x, wu g. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2915-9. doi: 10.1016/j.bmcl.2006.03.009. Epub 2006 Mar 20. Bioorg Med Chem Lett. 2006. PMID: 16546381

2

Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases.

Wen X, Sun H, Liu J, Wu G, Zhang L, Wu X, Ni P. Wen X, et al. Among authors: wu x, wu g. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4944-8. doi: 10.1016/j.bmcl.2005.08.026. Bioorg Med Chem Lett. 2005. PMID: 16169219

3

Synthesis and biological evaluation of sulfonylurea and thiourea derivatives substituted with benzenesulfonamide groups as potential hypoglycemic agents.

Zhang HB, Zhang YA, Wu GZ, Zhou JP, Huang WL, Hu XW. Zhang HB, et al. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1740-4. doi: 10.1016/j.bmcl.2009.01.082. Epub 2009 Jan 29. Bioorg Med Chem Lett. 2009. PMID: 19216076

4

De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints.

Wu G, Zhang Z, Chen H, Lin K. Wu G, et al. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2345-52. doi: 10.1016/j.bmcl.2015.04.035. Epub 2015 Apr 17. Bioorg Med Chem Lett. 2015. PMID: 25937012

5

[Design, synthesis and hypoglycemic activity of alpha-benzylsuccinic acid derivatives].

Wang YL, Zhong Z, Wu GZ, Chang Y. Wang YL, et al. Yao Xue Xue Bao. 2009 May;44(5):491-5. Yao Xue Xue Bao. 2009. PMID: 19618724 Chinese.

6

Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.

Tong X, Ma H, Amadi SW, Ma L, Wu G. Tong X, et al. Among authors: wu g. Naunyn Schmiedebergs Arch Pharmacol. 2015 Aug;388(8):831-41. doi: 10.1007/s00210-015-1112-7. Epub 2015 May 6. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25943026

7

Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest.

Zhu L, Zhao L, Wang H, Wang Y, Pan D, Yao J, Li Z, Wu G, Guo Q. Zhu L, et al. Among authors: wu g. Toxicol Lett. 2013 May 23;219(2):107-15. doi: 10.1016/j.toxlet.2013.01.019. Epub 2013 Mar 5. Toxicol Lett. 2013. PMID: 23470866

8

I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle.

Lu N, Zhan M, Gao C, Wu G, Zhang H. Lu N, et al. Among authors: wu g. Thromb Res. 2012 Oct;130(4):e209-15. doi: 10.1016/j.thromres.2012.07.022. Epub 2012 Aug 19. Thromb Res. 2012. PMID: 22909828

9

Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.

Wu GZ, Hong G, Zhang WP, Zhang HB. Wu GZ, et al. Arzneimittelforschung. 2009;59(11):550-6. doi: 10.1055/s-0031-1296443. Arzneimittelforschung. 2009. PMID: 20066963

10

Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound.

Ma L, Lu N, Wu G. Ma L, et al. Among authors: wu g. Platelets. 2015;26(4):342-8. doi: 10.3109/09537104.2014.912749. Epub 2014 May 15. Platelets. 2015. PMID: 24832568 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,386 results

Search Page

Filters